Billings Clinic
Especially For:

Clinical Trials

Title   Lung Cancer: H3E-US-130 Cancer Stage IIIB or IV NSCLC
Description   Randomized, open-label, Phase 3 study of Pemetrexed +Carboplatin followed by maintenance pemetrexed vs Paclitaxel + Carboplatin and bevacizumab followed by maintenance bevacizumab in Pts with advanced NSCLC of Non squamous histology
IRB Number   H3E-US-130
Category   Lung Cancer
Inclusion/Notes   Treated brain metastates is allowed.
Stage 4 nonoperable, no Prior Systemic Treatment, Radiation allowed, No Squamous histology
Status   Active
Start Date   10/10/2009
Principal Investigator (PI)   Jorge Nieva, MD
Physician Profile   Medical Oncologist
Contact Name   Judy Miller RN
Contact Email   jmiller4@billingsclinic.org
Phone   (406) 435-7482
Fax   (406) 435-7489
Funding Source   NCI
Print This Page
Email to a Friend
Home | Contact | Site Map | Site Privacy Policy | Terms & Conditions | Patient Privacy Policy | Medical Records | Fast Command
2800 10th Ave. North | P.O. Box 37000 | Billings, Montana 59107 | 406.238.2500
© Copyright 2014 Billings Clinic. All Rights Reserved.